Medical Grants, Fellowships, Journal Clubs and Rounds Program

Gilead accepts grant applications for projects and initiatives from healthcare and third-party organizations that support the shared ambition of Getting to Zero. The Medical Grants program can be used to support projects and initiatives focusing on the following areas:

• Zero new HIV transmissions:
• Testing initiatives including those in non-traditional settings to reduce late diagnosis.
• Prevention awareness initiatives or non-traditional healthcare navigators.
• Community-led initiatives to increase engagement in prevention and care.
• Improving wellbeing and reducing stigma towards people living with and at risk of HIV.
• Zero difference in HIV-related stigma, health outcomes and quality of life for people living with HIV:
• Community outreach and educational programs: Innovative community outreach projects that reach populations that need greater health support through engagement, education and empowerment.
• Supporting projects that will specifically help tackle inequalities for people living with HIV in healthcare and improve the experiences of people from marginalized communities.
• Establishing novel patient support programs or tools.
• Zero persons lost to care:
• Finding and re-engaging people lost to care back within HIV health services.
• Identifying, engaging and supporting communities who are at risk of being lost to care.
• Implementing strategies to improve retention in care.
• Demonstrating the role of a cross-sector approach to supporting people to engage in their care

The 2025 application windows for HIV are open from March 3rd to April 18th and September 1st to October 17th.

The Journal Club and Rounds, and Fellowships Grant program will also accept funding requests to support proposals that focus on HIV treatment and prevention. Applications for Journal Clubs, Rounds and Fellowship Grants are accepted year-round.

The Liver Disease Medical Grants Program will support innovative projects and initiatives that ultimately help advance Canada’s efforts of reaching the World Health Organization’s viral hepatitis elimination goals by 2030, Gilead is seeking applications for screening and linkage-to-care (SLTC) projects as well as education and advocacy projects through its grants program with the objective of addressing gaps that help patients in priority settings and populations.

Areas of focus include, but are not limited to:

• Projects addressing priority populations in HBV, HCV and HDV such as: Immigrants and newcomers, Persons who use Drugs (PWUD), Indigenous peoples, people with a history of incarceration, and others.
• Implementation or improvement of models that facilitate linkage to and retention in care (including new testing approaches or settings)
• Interventions or activities that simplify and strengthen the patient journey to improve the care cascade or removal of patient barriers

The 2025 application windows for Liver Disease are open from March 3rd to April 18th and September 1st to October 17th.

The Journal Club and Rounds, and Fellowship Grants program will also support proposals that implement new initiatives focused on improving liver disease care in those living with HCV, HDV, HBV and PBC. Applications for Journal Clubs, Rounds and Fellowship Grants are accepted year-round.

The Medical Grants Program is looking to support projects and initiatives which ultimately lead to an improvement in oncology care. Projects designed to tackle inequalities in cancer care among patient groups with poorer outcomes and/or access to care are particularly welcome. Priority will be given to those projects that focus on patients with breast cancer.

The Gilead Medical Grants Program funding can be used to support a variety of projects including, but not limited to:

• Audits or data reviews assessing patient profiles, disease outcomes and treatment patterns.
• Setting up new infrastructure for better diagnosis or detection of disease, including increased disease awareness in community settings and among members of the public.
• Establishing novel patient support programs or tools.
• New protocols to facilitate improved efficiency in patient care pathways.
• Frameworks to improve monitoring of patient-reported outcome measures or quality of life instruments or educational tools for patients and caregivers

The 2025 application windows for Oncology & Hematology are open from March 3rd to April 18th and September 1st to October 17th.

The Journal Clubs and Rounds and Fellowship Program is looking to support projects and initiatives which lead to an improvement in oncology care. Applications for Journal Clubs, Rounds and Fellowship Grants are accepted year-round.

The Medical Grants Program is also interested in supporting projects that focus on the CAR T patient pathway. This can include, but is not limited to, activities such as:

• Initiatives to facilitate improved efficiency in patient care and shared care pathways between referring and CAR T treatment centres.
• Audits or data reviews assessing patient profiles, disease outcomes, access to care and treatment patterns.
• Initiatives to improve monitoring of patient-reported outcomes or quality of life measures.
• Educational tools for healthcare professionals, patients and caregivers.
• New infrastructure/processes established for better diagnosis or detection of disease, or prediction or monitoring of safety and efficacy outcomes to treatment.

The 2025 application windows for CAR T are open from March 3rd to April 18th and September 1st to October 17th.

The Journal Clubs and Rounds and Fellowship Program is looking to support projects and initiatives which lead to an improvement in care for patients with hematological malignancies.  Applications for Journal Clubs, Rounds and Fellowship Grants are accepted year-round.